S. Seber
Impact in
-
- Chronic Kidney Disease and Diabetes
Papers in
- Oncology 17
- Inflammatory Biomarkers in Disease Prognosis 7
- Lung Cancer Research Studies 4
- Cancer Treatment and Pharmacology 2
-
- Breast Cancer Treatment Studies 11
- Co-authors
- Taner Korkmaz (8 shared papers)Yüksel Altuntaş (5 shared papers)Sema Uçak (4 shared papers)Okcan Basat (3 shared papers)Gül Başaran (5 shared papers)Özlem Harmankaya (1 shared paper)Mürvet Yılmaz (1 shared paper)Nazım Serdar Turhal (3 shared papers)
- Journals
- Medicine (2 papers)Critical Reviews in Oncology/Hematology (2 papers)OncoTargets and Therapy (2 papers)Journal of Geriatric Oncology (2 papers)Supportive Care in Cancer (2 papers)
- Partner nations
- Türkiye
In The Last Decade
S. Seber
51 papers receiving 554 citations
Peers
Comparison fields: 5 of 75
- Drug Discovery 2
- Nephrology 47
- Geriatrics and Gerontology 16
- Oncology 93
- Cancer Research 40
Countries citing papers authored by S. Seber
This map shows the geographic impact of S. Seber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Seber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Seber more than expected).
Fields of papers citing papers by S. Seber
This network shows the impact of papers produced by S. Seber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Seber. The network helps show where S. Seber may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Seber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 49 | |
| 2 | 2004 | 48 | |
| 3 | 2005 | 47 | |
| 4 | 2015 | 43 | |
| 5 | 2013 | 41 | |
| 6 | 2013 | 38 | |
| 7 | 2006 | 23 | |
| 8 | 2024 | 23 | |
| 9 | 2006 | 22 | |
| 10 | 2022 | 21 | |
| 11 | 2010 | 18 | |
| 12 | 2020 | 18 | |
| 13 | 2012 | 17 | |
| 14 | Percutaneous autologous bone marrow grafting for simple bone cysts. | 1999 | 13 |
| 15 | 2012 | 11 | |
| 16 | 2016 | 11 | |
| 17 | 2003 | 10 | |
| 18 | 2014 | 10 | |
| 19 | 2014 | 10 | |
| 20 | 2023 | 10 |
About S. Seber
S. Seber is a scholar working on Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Rheumatology, having authored 60 papers that have together received 580 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers), Lung Cancer Research Studies (4 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Drug Discovery (2 citations), Nephrology (47 citations), Geriatrics and Gerontology (16 citations), Oncology (93 citations) and Cancer Research (40 citations). S. Seber has collaborated with scholars based in Türkiye. Frequent co-authors include Taner Korkmaz, Yüksel Altuntaş, Sema Uçak, Okcan Basat, Gül Başaran, Özlem Harmankaya, Mürvet Yılmaz, Nazım Serdar Turhal, Mahmut Gümüş and Dilek Yavuzer. Their work appears in journals such as Medicine, Critical Reviews in Oncology/Hematology, OncoTargets and Therapy, Journal of Geriatric Oncology and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.